Cargando…
T cell response in patients with COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the third zoonotic coronavirus to have an outbreak in the first two decades of the 21st century. Human-to-human transmission of this virus has threatened thousands of lives around the world. SARS-CoV-2 shares 79% and 50% sequence homol...
Autores principales: | Liu, Lian, Xu, Ling, Lin, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974945/ https://www.ncbi.nlm.nih.gov/pubmed/35402822 http://dx.doi.org/10.1097/BS9.0000000000000050 |
Ejemplares similares
-
Antibody responses in COVID-19 patients
por: Liu, Shuying, et al.
Publicado: (2020) -
T cell responses in patients with COVID-19
por: Chen, Zeyu, et al.
Publicado: (2020) -
Peculiarities of the T Cell Immune Response in COVID-19
por: Kudlay, Dmitry, et al.
Publicado: (2022) -
Decline in neutralising antibody responses, but sustained T‐cell immunity, in COVID‐19 patients at 7 months post‐infection
por: Chen, Jun, et al.
Publicado: (2021) -
Monocytic HLA-DR Expression in Immune Responses of Acute Pancreatitis and COVID-19
por: Liu, Shiyu, et al.
Publicado: (2023)